1. Home
  2. Stocks
  3. Alkem Share Price
  • Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Alkem Laboratories Share Price

    Large Cap
    ₹6,216.85
    -140.6 (-2.21%)
    • Advice
    • Hold
    18 September, 2024 02:43 BSE: 539523 NSE: ALKEM ISIN: INE540L01014

    Start SIP in Alkem Laboratories

    Start SIP

    Alkem Laboratories Performance

    Day Range

    • Low 6,183
    • High 6,358
    ₹ 6,216

    52 Week Range

    • Low 3,447
    • High 6,440
    ₹ 6,216
    • Open Price6,345
    • Previous Close6,357
    • Volume150949

    Alkem Laboratories Chart

    • Over 1 Month + 9.41%
    • Over 3 Month + 21.85%
    • Over 6 Month + 23.22%
    • Over 1 Year + 69.12%

    Alkem Laboratories Key Statistics

    P/E Ratio 36.2
    PEG Ratio 0.5
    Market Cap Cr
    Price to Book Ratio 6.9
    EPS 150.7
    Dividend 0.6
    Relative Strength Index 62.44
    Money Flow Index 76.48
    MACD Signal 206.61
    Average True Range 135.95

    Alkem Laboratories F&O

    Alkem Laboratories Futures Alkem Laboratories Option Chain

    Alkem Laboratories Investment Rating

    • Master Rating:

    • Alkem Laboratories has an operating revenue of Rs. 12,731.68 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 16% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 23% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Alkem Laboratories Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 2,5002,3652,4952,6352,2532,238
    Operating Expenses Qtr Cr 1,8791,9581,9251,9801,9191,906
    Operating Profit Qtr Cr 621408569655334332
    Depreciation Qtr Cr 646958595857
    Interest Qtr Cr 212121192122
    Tax Qtr Cr 586430-84775
    Net Profit Qtr Cr 583325504647271255
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 10,0549,321
    Operating Expenses Annual Cr 7,783-316
    Operating Profit Annual in Cr 1,9659,371
    Depreciation Cr 244230
    Interest Annual Cr 8286
    Tax Annual Cr 1340
    Net Profit Annual Cr 1,7470
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 1,687
    Cash from Investing Activity Annual Cr -866
    Cash from Financing Annual Activity Cr -959
    Net Cash Flow Annual Cr -138
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 10,5550
    Fixed Assets Annual Cr 1,8730
    Total Non Current Assets Annual Cr 5,9980
    Total Current Assets Annual Cr 8,0400
    Total Assets Annual Cr 14,0380
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 8830
    ROE Annual % 170
    ROCE Annual % 190
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 233
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3,0322,9363,3243,4402,9682,903
    Operating Expenses Qtr Cr 2,4232,5342,6162,6932,5792,549
    Operating Profit Qtr Cr 609402708747389353
    Depreciation Qtr Cr 808370747278
    Interest Qtr Cr 292725303029
    Tax Qtr Cr 6963513365144
    Net Profit Qtr Cr 54529459562128771
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 12,97811,815
    Operating Expenses Annual Cr 10,4229,990
    Operating Profit Annual in Cr 2,2451,609
    Depreciation Cr 299310
    Interest Annual Cr 112107
    Tax Annual Cr 212298
    Net Profit Annual Cr 1,796984
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 1,9481,683
    Cash from Investing Activity Annual Cr -1,009113
    Cash from Financing Annual Activity Cr -1,145-1,761
    Net Cash Flow Annual Cr -20535
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 10,3129,045
    Fixed Assets Annual Cr 2,6152,593
    Total Non Current Assets Annual Cr 5,1635,027
    Total Current Assets Annual Cr 10,4128,730
    Total Assets Annual Cr 15,57513,757
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 896789
    ROE Annual % 1711
    ROCE Annual % 1915
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2016
    Invest in Alkem Laboratories

    Alkem Laboratories Technicals

    EMA & SMA

    Current Price
    ₹6,216.85
    -140.6 (-2.21%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹6,117.43
    • 50 Day
    • ₹5,783.44
    • 100 Day
    • ₹5,491.87
    • 200 Day
    • ₹5,119.00
    • 20 Day
    • ₹6,115.83
    • 50 Day
    • ₹5,676.74
    • 100 Day
    • ₹5,378.07
    • 200 Day
    • ₹5,185.80

    Alkem Laboratories Resistance and Support

    PIVOT
    ₹6,252.49
    Resistance
    First Resistance 6,322.32
    Second Resistance 6,427.78
    Third Resistance 6,497.62
    RSI 62.44
    MFI 76.48
    MACD Single Line 206.61
    MACD 194.49
    Support
    First Support 6,147.02
    Second Support 6,077.18
    Third Supoort 5,971.72

    Alkem Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 152,425 7,500,834 49.21
    Week 156,013 8,429,382 54.03
    1 Month 248,900 13,998,146 56.24
    6 Month 276,499 15,569,674 56.31

    Alkem Laboratories Result Highlights

    Alkem Laboratories Synopsis

    NSE-Medical-Diversified

    Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9747.72 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2024. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.
    Market Cap 76,013
    Sales 9,995
    Shares in Float 5.26
    No of funds 301
    Yield 0.63
    Book Value 7.2
    U/D Vol ratio 2.2
    LTDebt / Equity
    Alpha 0.16
    Beta 0.62

    Alkem Laboratories Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 56.38%56.74%56.74%56.74%
    Mutual Funds 14.72%11.92%12.08%13.05%
    Insurance Companies 2.85%2.75%2.86%3.49%
    Foreign Portfolio Investors 8.69%9.11%8.49%6.03%
    Financial Institutions/ Banks
    Individual Investors 16.15%18.31%18.6%19.36%
    Others 1.21%1.17%1.23%1.33%

    Alkem Laboratories Management

    Name Designation
    Mr. Basudeo N Singh Executive Chairman
    Mr. Sandeep Singh Managing Director
    Mrs. Madhurima Singh Executive Director
    Mr. Srinivas Singh Executive Director
    Mr. Mritunjay Kumar Singh Executive Director
    Mr. Sarvesh Singh Executive Director
    Mr. Sujjain Talwar Independent Director
    Mr. Arun Kumar Purwar Independent Director
    Ms. Sangeeta Singh Independent Director
    Ms. Sudha Ravi Independent Director
    Mr. Narendra Kumar Aneja Independent Director

    Alkem Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Alkem Laboratories Corporate Action

    Date Purpose Remarks
    2024-08-09 Quarterly Results
    2024-05-29 Audited Results & Final Dividend
    2024-02-09 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-10 Quarterly Results
    Date Purpose Remarks
    2024-08-10 FINAL Rs.5.00 per share(250%)Final Dividend
    2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
    2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
    2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
    2023-02-18 SPECIAL Rs.25.00 per share(1250%)Special Dividend

    Alkem Laboratories MF Shareholding

    Name Amount(cr)
    ICICI Prudential Bluechip Fund Growth 64,223
    ICICI Prudential Balanced Advantage Fund Growth 61,103
    Kotak Equity Arbitrage Fund Growth 53,423
    Kotak Emerging Equity Scheme Growth 51,366
    ICICI Prudential Multi-Asset Fund Growth 48,201

    Alkem Laboratories FAQs

    What is Share Price of Alkem Laboratories ?

    Alkem Laboratories share price is ₹6,216 As on 18 September, 2024 | 02:29

    What is the Market Cap of Alkem Laboratories ?

    The Market Cap of Alkem Laboratories is ₹74331.8 Cr As on 18 September, 2024 | 02:29

    What is the P/E ratio of Alkem Laboratories ?

    The P/E ratio of Alkem Laboratories is 36.2 As on 18 September, 2024 | 02:29

    What is the PB ratio of Alkem Laboratories ?

    The PB ratio of Alkem Laboratories is 6.9 As on 18 September, 2024 | 02:29

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.